Company Filing History:
Years Active: 2022
Title: Christine Kratt: Innovator in Autoimmune Disease Treatment
Introduction
Christine Kratt is a notable inventor based in Fort Collins, CO (US). She has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases. Her innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Christine Kratt holds a patent titled "Methods of treating autoimmune disease using a domain antibody directed against CD40L." This patent focuses on methods for treating various autoimmune diseases, including primary immune thrombocytopenia (ITP), solid organ transplant rejection, graft-related disease, pemphigus vulgaris, systemic sclerosis, and myasthenia gravis. The invention involves antibody polypeptides that specifically bind to human CD40L without activating platelets. The methods may include at least one administration cycle with a dose of the antibody polypeptide administered intravenously, ranging from about 75 mg to about 1500 mg. This innovative approach aims to normalize platelet counts in human patients.
Career Highlights
Christine is associated with Bristol-Myers Squibb Company, where she continues to advance her research and development efforts. Her work is pivotal in the ongoing fight against autoimmune diseases, showcasing her dedication to improving patient outcomes.
Collaborations
Christine collaborates with esteemed colleagues, including Marek Honczarenko and Vaishali Shah. These partnerships enhance her research capabilities and contribute to the success of her innovative projects.
Conclusion
Christine Kratt's contributions to the field of autoimmune disease treatment exemplify her commitment to innovation and patient care. Her patent reflects a significant advancement in medical science, and her work continues to inspire future developments in the field.